SK Life Science, Inc. Presents XCOPRI CV Data at the AES 2024
December 9, 2024
SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., presented data